Revision history of "Preclinical study with messenger RNA for etiological treatment of intermittent acute porphyria. Efficacy and safety in non-human primates and in a new model of liver porphyria in rabbit." (Q3167120)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 October 2024

  • curprev 10:5210:52, 8 October 2024DG Regio talk contribs 86,217 bytes +4 Changed label, description and/or aliases in pt
  • curprev 10:5210:52, 8 October 2024DG Regio talk contribs 86,213 bytes −14 Set a claim value: summary (P836): A porfiria aguda intermitente (IAPA), a haploinsuficiência de porfobilinogénio desaminase hepática (PBGD), caracteriza-se por crises abdominó-psíquicas-neurológicas intermitentes associadas à acumulação sérica de precursores hepáticos do hemo. Ensaios em ratinhos PAI e num novo modelo de coelho propõem a administração sistémica de ARN mensageiro em nanopartículas lipídicas como um tratamento etiológico promissor para MYP. Esta terapia funciona dentr...

20 March 2024

20 December 2023

12 June 2023

10 June 2023

18 August 2022

  • curprev 02:0802:08, 18 August 2022DG Regio talk contribs 84,955 bytes +58,828 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 16:5416:54, 12 October 2021DG Regio talk contribs 13,445 bytes +246 Changed label, description and/or aliases in en: translated_label
  • curprev 16:5416:54, 12 October 2021DG Regio talk contribs 13,199 bytes +2,647 Created claim: summary (P836): Intermittent acute porphyria (IAPA), haploinsufficiency of liver porfobilinogen desaminase (PBGD), is characterised by intermittent abdomino-psychic-neurological crises associated with serum accumulation of hepatic haemo precursors. Trials in PAI mice and in a new rabbit model propose systemic administration of messenger RNA in lipid nanoparticles as a promising etiological treatment for MYP. This therapy works within a few hours and maintains e...

10 October 2021

9 October 2021

8 October 2021